COMMUNIQUÉS West-GlobeNewswire

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
04/05/2026
Live webcast on Friday, May 8, 2026, beginning at 12:30 PM ET Event will feature Phase 1 clinical data for BGE-102 and the therapeutic rationale for development in atherosclerotic cardiovascular disease (ASCVD) and [...]
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
04/05/2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Daniel Faga [...]
Cellectis to Report First Quarter Financial Results on May 11, 2026
04/05/2026
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
04/05/2026
BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announced that it expects to [...]
CooperCompanies Appoints Paul Keel to its Board of Directors
04/05/2026
SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director [...]
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
04/05/2026
MELBOURNE, Australia and INDIANAPOLIS, May 05, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the publication of a new independent analysis of Phase 3 ZIRCON [...]
Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026
04/05/2026
Company to Host Conference Call and Webcast Tuesday May 5 at 8:00 AM Eastern Time SOUTH SAN FRANCISCO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will report [...]
ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
04/05/2026
Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in post-abiraterone mCRPC, expected to initiate in 1H 2026 Reported rinzimetostat data in [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/05/2026
SAN FRANCISCO, May 04, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Kyntra Bio to Report First Quarter 2026 Financial Results
04/05/2026
SAN FRANCISCO, May 04, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce first quarter 2026 financial results on Monday, May 11 after market close. Kyntra Bio will also conduct a conference call on [...]
SYNC Supplement Claims Evaluated: The Revive Daily Sunlight Loophole Formula for Healthy Circadian-Rhythm Support
04/05/2026
How the Sunlight Loophole Circadian Rhythm Supplement Works: Clock Gene Support, Morning Metabolism Alignment, and DSHEA Ingredient Standards Explained Aurora, CO, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
04/05/2026
Déclaration de transactions sur actions propres Paris, France (4 mai 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, et, pour les opérations réalisées postérieurement à l [...]
Confluent Medical Technologies Announces Nitinol Wire Center of Excellence
04/05/2026
Confluent Unveils New Nitinol Wire Manufacturing Facility in Hyderabad, India SCOTTSDALE, Ariz., May 04, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent), a leading medical device and materials [...]
Xpress Wellness Acquires Wichita’s Mental Health Practice Midwest Counseling Services
04/05/2026
Acquisition furthers Xpress Wellness’ future growth in behavioral health in Kansas and Adjacent State Key facts of this press release: Xpress Wellness acquired Wichita’s Midwest Counseling Services on April 1, 2026 [...]
Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist
04/05/2026
Nanomedicine expert joins Massachusetts Biomedical Initiatives (MBI) lab in Worcester to advance RNA therapeutics for musculoskeletal disease WORCESTER, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Eascra Biotech , a [...]
EssilorLuxottica: Disclosure of transactions in own shares
04/05/2026
Disclosure of transactions in own shares Paris, France (May 4, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting held on April 30, 2025, and, with respect to transactions [...]
Orion Corporation: Managers’ transactions – Sophie Papa
04/05/2026
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MAY 2026 at 16.00 EEST Orion Corporation: Managers’ transactions – Sophie Papa Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596 [...]
BioMogging Brings Research-Backed Rigour to Looksmaxxing as the Discipline Goes Mainstream
04/05/2026
Independent editorial platform BioMogging now covers more than 200 peptides, research chemicals, and looksmaxxing compounds with sourced protocols and free precision tools, offering a vendor-neutral reference for a [...]
Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
04/05/2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]

Pages